Template:ICH Treatment: Difference between revisions
| Line 15: | Line 15: | ||
**Consider modest reduction of BP (e.g. MAP of 110 or target BP of 160/90) | **Consider modest reduction of BP (e.g. MAP of 110 or target BP of 160/90) | ||
Dosing [[nicardipine]] in ICH: Start nicardipine at 5mg/hr and increase q5min by 2.5mg until the target blood pressure is achieved and then immediately titrate down to maintenance infusion of 3mg/hr. | *Dosing [[nicardipine]] in ICH: Start nicardipine at 5mg/hr and increase q5min by 2.5mg until the target blood pressure is achieved and then immediately titrate down to maintenance infusion of 3mg/hr. | ||
Dosing [[labetolol]] in ICH: Start with labetolol 20mg over 1-2 minutes and then 20mg q3-5 mins until target blood pressure is achieved and then start an infusion of 1-8mg/min. | *Dosing [[labetolol]] in ICH: Start with labetolol 20mg over 1-2 minutes and then 20mg q3-5 mins until target blood pressure is achieved and then start an infusion of 1-8mg/min. | ||
===Reverse coagulopathy=== | ===Reverse coagulopathy=== | ||
Revision as of 03:02, 22 October 2018
Elevating head of bed
- 30 degree elevation will help decrease ICP[1]
Seizure Prophylaxis
- For example: Keppra 1,000mg IV load
Blood Pressure
- Few studies on optimal management however many guidelines recommending moderate reduction, often a goal systolic of 140-160's
- Rapid SBP lowering <140 has been advocated with early research showing improved functional outcome[2], but more recent work has found no difference between SBP <140 and <180[3]
- SBP >200 or MAP >150
- Consider aggressive reduction w/ continuous IV infusion
- SBP >180 or MAP >130 and evidence or suspicion of elevated ICP
- Consider reducing BP using intermittent or continuous IV meds to keep CPP >60-80
- SBP >180 or MAP >130 and NO evidence or suspicion of elevated ICP
- Consider modest reduction of BP (e.g. MAP of 110 or target BP of 160/90)
- Dosing nicardipine in ICH: Start nicardipine at 5mg/hr and increase q5min by 2.5mg until the target blood pressure is achieved and then immediately titrate down to maintenance infusion of 3mg/hr.
- Dosing labetolol in ICH: Start with labetolol 20mg over 1-2 minutes and then 20mg q3-5 mins until target blood pressure is achieved and then start an infusion of 1-8mg/min.
Reverse coagulopathy
- See anticoagulant reversal for life-threatening bleeds if on a known anticoagulant (e.g. heparin, coumadin, rivaroxaban)
Antiplatelet
- Includes aspirin, prasagril, clopidogrel
- Consider Desmopressin (0.3mcg/kg)
- Transfusion of platelets has been shown to increase mortality (PATCH trial)
- In traumatic brain injury, platelet transfusion has been shown to reduce the degree of platelet inhibition, but no change in clinical outcomes[4]
- Consider platelet transfusion in patients with ICH for platelet count <50,000, but many hematologists and neurosurgeons recommend platelet transfusion for ICH with platelet count < 100,000 despite lack of evidence for improved outcomes, especially if the patient requires emergency surgery
- ↑ http://stroke.ahajournals.org/content/38/6/2001.full
- ↑ Anderson CS, Heeley E, Huang Y, et al. Rapid blood-pressure lowering in patients with acute intracerebral hemorrhage. N Engl J Med. 2013; 368:2355-2365.
- ↑ Qureshi AI, Palesch YY, Barsan WG, et al. Intensive Blood-Pressure Lowering in Patients with Acute Cerebral Hemorrhage. N Engl J Med. 2016; 1-11. [Epub ahead of print].
- ↑ Platelet Transfusion Does Not Improve Outcomes In Patients With Brain Injury On Antiplatelet Therapy Holzmacher, J.L., et al, Brain Injury 32(3):325, 2018